Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Esperion Theraptc (NQ: ESPR )

9.140 USD -0.160 (-1.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 834,327
Open 9.340
Bid (Size) 9.100 (4)
Ask (Size) 9.160 (2)
Prev. Close 9.300
Today's Range 9.100 - 9.490
52wk Range 9.100 - 39.49
Shares Outstanding 28,277,493
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ESPERION to Host Investor Webinar on the Current Landscape and Future Directions in the Treatment of Elevated Cholesterol
From GlobeNewswire News Releases
Interesting ESPR Put And Call Options For June 2022
Investors in Esperion Therapeutics Inc (ESPR) saw new options become available this week, for the June 2022 expiration. One of the key data points that goes into the price an option buyer is willing to... 
Tags Stocks
From Market News Video

Performance

YTD
-67.02%
-67.02%
1 Month
-24.40%
-24.40%
3 Month
-46.80%
-46.80%
6 Month
-66.01%
-66.01%
1 Year
-73.97%
-73.97%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
Tags IMRN EFTR ECOR
From Benzinga
How The Pieces Add Up: LABU Targets $101
Tags ETFs
From ETF Channel
Most Heavily Shorted Stocks
Tags Market News Stocks / Equities
From TalkMarkets
Oversold Conditions For Esperion Therapeutics
Tags Stocks
From Market News Video
44 Biggest Movers From Yesterday
Tags AMN WTRH Markets
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
Tags ESPR Intraday Update PROG
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Tags STOK SGMO PRLD
From Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Tags PTPI CCXI MESO
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Tags LPCN OMER HARP
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.